Merck TICE® BCG Bacille Calmette-Guerin vaccine is an attenuated, live culture preparation.Read more...
BBV87 Chikungunya Vaccine
Bharat Biotech BBV87 vaccine candidate is an inactivated whole virion vaccine based on a strain derived from an East, Central, South African (ECSA) genotype.Read more...
Bebtelovimab (LY-CoV1404) Monoclonal Antibody
Bebtelovimab (LY-CoV1404, LY3853113) monoclonal antibody that treats mild to moderate COVID-19.Read more...
Bexsero Meningitis B Vaccine
Bexsero (MenB-4C) vaccine contains different proteins taken from group B Neisseria meningitidis bacteria and prevents Gonorrhea.Read more...
Beyfortus (Nirsevimab) RSV Antibody
Beyfortus Nirsevimab-alip RSV monclonal antibody is a single-dose passive immunization for infants.Read more...
BioThrax Anthrax Vaccine
BioThrax, Anthrax Vaccine Adsorbed, is made from cell-free filtrates of microaerophilic cultures of an avirulent, nonencapsulated strain of Bacillus anthracis.Read more...
BNT111 Melanoma Vaccine
BioNTech BNT111 Melanoma Vaccine candidate is a therapeutic melanoma cancer vaccineRead more...
BNT163 Herpes Vaccine
BNT163 is an HSV vaccine candidate based on BioNTech's mRNA platformRead more...
BNT165 Malaria Vaccine
BioNTech BNT165 is an mRNA vaccine candidate preventing malaria.Read more...
Boostrix Vaccine
Boostrix is a combination Tdap vaccine that is used to help prevent tetanus, diphtheria, and pertussis infections.Read more...
BPL-1357 Universal Flu Vaccine
BPL-1357 Universal Flu Vaccine candidate is being tested in a Phase 1 trial by the U.S. NIHRead more...
Brilacidin COVID-19 Therapeutic
Brilacidin is a synthetic, defensin-mimetic drug candidate exhibiting broad-spectrum antiviral activityRead more...
BriLife Vaccine
Brilife (IIBR-100) is a viral vector vaccine containing a recombinant vesicular stomatitis virus, an animal virus that does not cause disease in humans, and the spike protein was replaced with that of the SARS-CoV-2 coronavirus.Read more...
Butantan-DV Dengue Vaccine
Butantan-DV Dengue Vaccine Clinical Trials, Dosage, Indication, News, Side Effects
As of September 2024, Butantan Institute's single-dose, tetravalent, live attenuated Butantan-DV Dengue Vaccine is conducting phase 3 clinical trials. The... Read more...
BVRS-GamVac-Combi MERS Vaccine
BVRS-GamVac-Combi MERS Vaccine candidate is intended to prevent Middle East Respiratory SyndromeRead more...